Subsequently, heterozygous de novo mutations in ATP1A1 were reported in individuals with renal hypomagnesemia, refractory seizures, and intellectual disability,28 and in a child with spastic paraplegia and intellectual disability with normal nerve conduction.29 Here, ATP1A1 is linked to Spastic paraplegia.